The progress of drug discovery to the market typically requires 12 to 15 years, during which substantial financial investments are continuously made for various research and testing activities. The complexity and multifactorial nature of the disease, the complexity of the drug development process, the size of the chemi...
Shao-Qing Du, Xue-Ping Hu, E. De Clercq et al.· The Innovation Medicine· 0 citations
This perspective critically evaluates recent advances in the development of small-molecule anti-SFTSV agents, organized through a dual framework encompassing both viral life cycle targets and host-dependent pathways.
Zhou Tan, Ji-Wei Zhang, Chun-Hong Yin et al.· Journal of Medicinal Chemist...· 0 citations
A multi-objective optimization workflow for the NVR 3-778 is reported by integrating structure-based fragment growing with systematic medicinal chemistry optimization, activity prediction, and multitask prediction of drug-like properties to highlight 11B-6 as a promising next-generation HBV CAM.
Shuo Wang, Miao-Chen Xu, Fei-Yue Ma et al.· Journal of Medicinal Chemist...· 0 citations
Three core medicinal chemistry strategies, including side-chain replacement, conformational constraint, and scaffold hopping, are applied to optimize the lead compound and validate this strategy through representative case studies and summarize key practical challenges: off-target toxicity and difficulties in modifying...
Shaoqing Du, Kai Tang, Jinheng Li et al.· Journal of Medicinal Chemist...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.